Sign in
4

Changes in Ownership

Greenwich LifeSciences, Inc. Filed Acc 0001493152-23-032407

CEO and CFO bought 1,000 shares at $9.48 ($9,480)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Patel Snehal CEO and CFO 2023-09-11 Purchase +1,000 $9.48 $9,480 5,292,177 D
Open-market purchases · 1,000 sh · avg $9.48 · $9,480
Loading xslF345X05/ownership.xml…